Fig. 3From: Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disordersMonitoring of anticoagulation by measuring activated clotting time (ACT) levels during and after intraportal infusion of HepaStem in patients (n = 11). ACT levels (targeted values 200–350 s; dotted horizontal lines) are represented for each patient during cell infusions (1–10)Back to article page